NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 12, 2024 — Tonix Pharmaceuticals reports Q3 2024 financial results and highlights drug pipeline advancements for fibromyalgia, mpox vaccines, and cocaine intoxication. FDA Fast Track designation underscores commitment to CNS disorders and infectious disease treatments.
November 12, 2024 — Avant Technologies and Ainnova Tech have partnered to revolutionize early disease detection through advanced technology, aiming to make retinal scanning accessible and scalable for the global population. The joint venture's focus on detecting diseases like diabetic retinopathy and cardiovascular disease early could significantly impact healthcare outcomes and prevent blindness in patients, addressing the global need for early disease detection and prevention.
November 12, 2024 — Mainz Biomed is making strides in cancer diagnostics with its revolutionary ColoAlert product and upcoming FDA trials. The collaboration with Liquid Biosciences for PancAlert and the support of brand ambassadors signal a positive impact on early cancer detection and market growth.
November 12, 2024 — The American Heart Association updates CPR guidance for drowning victims, reaffirming the importance of rescue breaths. Learn more about the updated recommendations and their impact on cardiac arrest outcomes.
November 11, 2024 — Annovis Bio (ANVS) provides update on lead drug candidate buntanetap for Alzheimer’s and Parkinson’s diseases, securing FDA clearance for Phase 3 trials. Significant progress made with new funds, patents, and team expansion to support clinical trials.
November 11, 2024 — Preliminary research presented at the American Heart Association’s Resuscitation Science Symposium 2024 suggests that 911 dispatcher assistance could improve the chances of receiving bystander CPR during a cardiac arrest. The findings highlight the critical role of the telecommunicator in reducing sex disparities in receiving CPR and the importance of the first link in the out-of-hospital cardiac arrest chain of survival.
November 11, 2024 — A preliminary study presented at the American Heart Association’s Scientific Sessions 2024 shows that the MESA heart disease risk score works well without race. This challenges the use of race in risk prediction models and highlights the potential impact on patient care.
November 11, 2024 — Bystander CPR up to 10 minutes after cardiac arrest may protect brain function, according to a new study. The findings highlight the critical importance of quick action in emergencies and the need for widespread CPR training programs. This news could potentially improve survival rates from sudden cardiac arrest.
November 11, 2024 — Impact BioMedical Inc. (IBO) is set to make significant strides in healthcare with its recent innovations and expanding intellectual property. With a successful IPO and major partnerships, Impact BioMedical is well-prepared to become a transformative force in human healthcare.
November 11, 2024 — Preliminary study presented at AHA Scientific Sessions 2024 reveals the link between historical redlining and current health issues in neighborhoods. The findings emphasize the need for interventions to improve access to healthy food and address social determinants of health.
November 11, 2024 — New study reveals elevated cardiovascular disease risk in individuals with chronic kidney disease and Type 2 diabetes, emphasizing the importance of early risk identification and intervention for improved cardiovascular health.
November 11, 2024 — Preliminary study at the American Heart Association’s Scientific Sessions 2024 reveals lack of sexual health information for older adults with heart conditions, highlighting the need for health care professionals to prioritize discussing sexual health with heart disease patients.
November 11, 2024 — Out-of-hospital cardiac arrest survival rates dropped significantly at the onset of the COVID-19 pandemic in 2020 and remained lower than pre-pandemic years, according to a preliminary study. The findings emphasize the need for targeted efforts to improve survival rates across all communities, especially in Black and Hispanic communities.
November 11, 2024 — A preliminary study presented at the American Heart Association’s Scientific Sessions 2024 reveals the ongoing impact of the fear of another heart attack on survivors' mental and emotional well-being. The study emphasizes the need for separate evaluation and support for this fear, underscoring the importance of extended follow-up and mental health care for heart attack survivors.
November 11, 2024 — An analysis of death certificate data reveals a concerning increase in cardiovascular disease deaths in rural areas and a decline in urban areas, highlighting widening rural-urban disparities in cardiovascular mortality. The findings underscore the urgent need for public health initiatives and policy interventions to reduce cardiovascular risk factors and improve access to healthcare in rural communities.
November 11, 2024 — New AI system uses high-speed video to detect high blood pressure and diabetes. Promising results from a preliminary study presented at the American Heart Association’s Scientific Sessions 2024. Potential game-changer for non-invasive health screenings.
November 11, 2024 — Preliminary study at AHA's Scientific Sessions 2024 reveals potential link between fluctuating cholesterol levels and increased risk of dementia. Understanding this association could lead to better monitoring and proactive interventions to prevent dementia.
November 11, 2024 — Exposure to high temperatures may triple the risk of irregular heart rhythm in people with implantable cardioverter defibrillators. The study highlights the need to understand and prevent conditions that trigger atrial fibrillation, emphasizing the potential impact of extreme temperatures on the risk of irregular heart rhythm in individuals with ICDs.
November 11, 2024 — A new study presented at the AHA's Scientific Sessions 2024 reveals the impact of socioeconomic status during early pregnancy on women's future heart health. The findings emphasize the need for preventive care and addressing disparities in healthcare access and affordability.
November 11, 2024 — The Fourth Annual Sickle Cell Caregiver Summit, sponsored by leading pharmaceutical companies, provides support, education, and networking opportunities for caregivers within the global sickle cell community. The event aims to uplift and empower caregivers and address critical needs within the sickle cell community.